# Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma

> **NCT00297141** · PHASE2 · COMPLETED · sponsor: **Austrian Breast & Colorectal Cancer Study Group** · enrollment: 60 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **DRUG:** Capecitabine
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT00297141
- **Lead sponsor:** Austrian Breast & Colorectal Cancer Study Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-12-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00297141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00297141, "Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00297141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*